J P Droz

1.9k total citations
33 papers, 1.3k citations indexed

About

J P Droz is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J P Droz has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in J P Droz's work include Testicular diseases and treatments (13 papers), Neuroblastoma Research and Treatments (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). J P Droz is often cited by papers focused on Testicular diseases and treatments (13 papers), Neuroblastoma Research and Treatments (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). J P Droz collaborates with scholars based in France, United States and Netherlands. J P Droz's co-authors include J. Beyer, Carsten Bokemeyer, Craig R. Nichols, Hans‐Joachim Schmoll, Christine Ménétrier‐Caux, Sophie D. Fosså, Christine Gennigens, A. Gerl, Alan Horwich and Lothar Kanz and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

J P Droz

30 papers receiving 1.3k citations

Peers

J P Droz

SURGE

PRM

NEURO

ONCOL

Jean Pierre Droz France

A. Norman United Kingdom

Harpal S. Dhaliwal India

Yang Feng China

Yuji Mizukami Japan

Rajesh Bandekar United States

B. W. Hancock United Kingdom

Daiva Bajorunas United States

Victoria M. Chia United States

R. G. Hahn United States

Jean Pierre Droz France

J P Droz

574 ×0.7

SURGE

217 ×0.5

PRM

98 ×0.3

NEURO

127 ×0.5

235 ×1.2

ONCOL

Citations per year, relative to J P Droz J P Droz (= 1×) peers Jean Pierre Droz

Countries citing papers authored by J P Droz

Since Specialization

Citations

This map shows the geographic impact of J P Droz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Droz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Droz more than expected).

Fields of papers citing papers by J P Droz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Droz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Droz. The network helps show where J P Droz may publish in the future.

Co-authorship network of co-authors of J P Droz

This figure shows the co-authorship network connecting the top 25 collaborators of J P Droz. A scholar is included among the top collaborators of J P Droz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Droz. J P Droz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fléchon, Aude, et al.. (2011). Treatment of uncommon malignant tumours of the bladder. Current Opinion in Urology. 21(5). 309–314. 9 indexed citations

Ismaili, Nabil, et al.. (2011). Rôle de la chimiothérapie dans la prise en charge du cancer de la vessie. Progrès en Urologie. 21(6). 369–382. 6 indexed citations

Girre, V., et al.. (2010). Potential drug interactions in elderly cancer patients. Critical Reviews in Oncology/Hematology. 78(3). 220–226. 48 indexed citations

Terret, C. & J P Droz. (2009). Définition et présentation de la cancérologie du sujet âgé. Progrès en Urologie. 19. S75–S79. 7 indexed citations

Fléchon, Aude, et al.. (2007). Management of clinical stage (CS) I and II patients with non-seminomatous germ cell tumors of the testis (NSGCTT) avoiding upfront retroperitoneal lymph node dissection (RPLND). Journal of Clinical Oncology. 25(18_suppl). 5090–5090.

Gennigens, Christine, Christine Ménétrier‐Caux, & J P Droz. (2006). Insulin-Like Growth Factor (IGF) family and prostate cancer. Critical Reviews in Oncology/Hematology. 58(2). 124–145. 118 indexed citations

Jonge, Maja J.A. de, J P Droz, Luis Paz‐Ares, et al.. (2004). Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors. Investigational New Drugs. 22(3). 329–333. 6 indexed citations

Droz, J P, Aude Fléchon, & C. Terret. (2002). Prostate cancer: management of advanced disease. Annals of Oncology. 13. 89–94. 7 indexed citations

Hartmann, J.T., C R Nichols, J P Droz, et al.. (2000). Hematologic Disorders Associated With Primary Mediastinal Nonseminomatous Germ Cell Tumors. JNCI Journal of the National Cancer Institute. 92(1). 54–61. 129 indexed citations

10.

Bouras, Marwan, et al.. (2000). Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type. Carcinogenesis. 21(4). 805–810. 16 indexed citations

11.

Beyer, J., A. Kramar, Romeo A. Mandanas, et al.. (1996). High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.. Journal of Clinical Oncology. 14(10). 2638–2645. 211 indexed citations

12.

Maulard, C, et al.. (1995). Phase I?II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer. Cancer Chemotherapy and Pharmacology. 36(3). 259–262. 49 indexed citations

13.

Farhat, Fadi, Stéphane Culine, C. Lhommé, et al.. (1995). [Desmoplastic small round cell tumors in adults: a new entity].. PubMed. 82(8). 665–73. 3 indexed citations

14.

Brausi, Maurizio, William G. Jones, Sophie D. Fosså, et al.. (1995). High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group. European Journal of Cancer. 31(10). 1622–1626. 26 indexed citations

15.

Rougier, P, M. Mahjoubi, P Lasser, et al.. (1994). Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. European Journal of Cancer. 30(9). 1269–1275. 56 indexed citations

16.

Culine, Stéphane, C. Lhommé, Joseph Kattan, et al.. (1994). Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary. European Journal of Cancer. 30(9). 1239–1244. 8 indexed citations

17.

Hillman, Gilda G., J P Droz, & Gabriel P. Haas. (1994). Experimental animal models for the study of therapeutic approaches in renal cell carcinoma.. PubMed. 8(1). 77–80. 22 indexed citations

18.

Räth, U., B.K. Upadhyaya, Hannes Böckmann, et al.. (1993). Role of Ondansetron plus Dexamethasone in Fractionated Chemotherapy. Oncology. 50(3). 168–172. 23 indexed citations

19.

Rougier, P, Mario Ghosn, G. Piot, et al.. (1992). Phase II Trial of 7-Day Continuous 5-Fluorouracil Infusion in the Treatment of Advanced Colorectal Carcinoma. Oncology. 49(1). 35–39. 8 indexed citations

20.

Ghosn, Mario, J P Droz, Christine Théodore, et al.. (1988). Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen. Cancer. 62(1). 24–27. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact